Plain-English translation of NCT04670874 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study invites adults with cutaneous lymphoma to complete surveys that measure how the disease affects your quality of life, including physical symptoms like itching, emotional wellbeing, and day-to-day functioning. Researchers will use your answers to better understand what patients with this condition experience and what support you need most. The study also tracks how different treatments and social support services help improve your quality of life over time.
While doctors know a lot about treating cutaneous lymphoma medically, there's less research on how the disease actually affects patients' lives — their emotional wellbeing, daily activities, and overall satisfaction. This study exists to fill that gap and help hospitals like City of Hope better support patients' mental and social needs alongside medical care.
You likely qualify if…
You likely don't qualify if…
You will be asked to complete a survey called the Skindex-29, which takes about 10 to 20 minutes and asks about your symptoms, emotions, and how cutaneous lymphoma affects your daily life. You may also be asked simple questions about itching and your medical background. These surveys will happen over time so researchers can track how you're doing and how treatments may help improve your quality of life.
AI-generated summary from trial data · Jun 15, 2026 · Not medical advice
United States
Collaborators
National Cancer Institute (NCI)
Enrollment target
~1,250 participants
Started
August 2023
Primary completion
January 2034
Age range
18 Years and older
Last updated on clinicaltrials.gov in January 2026.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.